Media Center

PRESS RELEASES (2005 Archives)

2005-11-02	TOPIGEN OUTLINES STRATEGY FOR RESPIRATORY DISEASE PRODUCT PIPELINE
2005-10-27	NicOx AND TOPIGEN SIGN AGREEMENT FOR NCX 1020 IN COPD AND OTHER RESPIRATORY DISEASES
2005-10-19	TOPIGEN INITIATES PHASE II CLINICAL TRIAL OF LEAD DRUG CANDIDATE FOR ASTHMA
2005-10-06	TOPIGEN ADDS TO SERIES B ROUND AN INVESTMENT OF CA$6 MILLION FROM CAISSE DE DEPOT ET PLACEMENT DU QUÉBEC
2005-09-12	TOPIGEN ANNOUNCES PRESENTATIONS AT INAUGURAL MEETING OF THE OLIGONUCLEOTIDE THERAPEUTICS SOCIETY
2005-06-08	TOPIGEN INTRODUCES FANA™ TECHNOLOGY, NEW 3 rd GENERATION CHEMISTRY FOR OLIGONUCLEOTIDE-BASED THERAPEUTICS
2005-04-06	TOPIGEN WINS TWO PRESTIGIOUS INDUSTRY AWARDS
2005-04-05	TOPIGEN NAMES G. JOHN MOHR CHIEF BUSINESS OFFICER
2005-03-16	TOPIGEN APPOINTS BIOPHARMACEUTICAL INDUSTRY EXECUTIVES GARY LESSING AND MICHAEL ATKIN TO ITS BOARD OF DIRECTORS
2005-03-14	TOPIGEN TO PRESENT AT SACHS-BLOOMBERG 4th ANNUAL BIOTECH FORUM
2005-03-03	TOPIGEN ANNOUNCES APPOINTMENTS OF JOHN C. SCHAFER AND ROBERT J. DELUCCIA TO ITS BOARD OF DIRECTORS
2005-02-17	TOPIGEN INITIATES PHASE I STUDY OF ASM8™, ITS INHALED ASTHMA PRODUCT. A UNIQUE APPROACH TO BLOCKING THE PROGRESSION OF ASTHMA BY INHIBITING MULTIPLE INFLAMMATORY PATHWAYS
2005-01-19	TOPIGEN APPOINTS Dr LOUISE PROULX AS VICE PRESIDENT, PRODUCT DEVELOPMENT